Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
A large part of the money that was made by banks and investment banks from 2004 through most of 2007 was made from mergers and acquisitions. When the credit markets fell apart, the financing for...
Published:
Last Updated:
According to Reuters, Obama faces backlash due to AIG (AIG) compensation issues which could set bank his efforts to salvage the financial system. Reuters reports that Lehman will put two of its...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) is stopping its Phase III clinical trial of Sutent early. This is generally a scare over adverse events, but not in this case. Sutent apparently has shown such a...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) just got its long-term ratings downgraded by Moody’s. It is amazing that bond ratings agencies still get to operate in a business as usual manner, but they do. Long gone...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive calls we have seen from analysts this Tuesday morning: Big Lots (BIG) Raised to Buy at Soleil. Corning (GLW) Raised to Buy at Collins...
Published:
Last Updated:
Citigroup (C) Still fears of nationalization or a larger bailout. Falls to $1.15. from a 52-week high of $27.35. GE (GE) Market not comforted that GE’s financial services are is not in trouble....
Published:
Last Updated:
These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens: Axsys Technologies...
Published:
Last Updated:
According to Reuters, the White House is finishing a bank rescue package , that involves investment by private equity. Reuters reports that a poll of analysts cut Q2 earnings forecasts. Reuters...
Published:
Last Updated:
These are some of the top pre-market analyst upgrades and positive calls we have seen this Monday morning: Adobe Systems (ADBE) Raised to Outperform at Oppenheimer. Alexion Pharmaceuticals (ALXN)...
Published:
A look at the companies which announced layoffs in December and January demonstrates that almost no industry is immune from job losses due to this contracting economy. Tech companies such as...
Published:
Last Updated:
These are some of the top analyst upgrades and positive calls we are seeing this Monday morning: Akamai (AKAM) Raised to Buy at Merriman Curhan Ford. Boston Scientific (BSX) Raised to Overweight at...
Published:
Last Updated:
According to Reuters, Republican may keep fighting Obama on the stimulus package. Reuters reports that Roche dropped its bid on Genentech (DNA) to $42 billion. Reuters writes that the Administration...
Published:
Last Updated:
Continuing jobless claims rose by 159,000 in the week ended Jan. 17 to a seasonally adjusted 4.78 million, the most since the government’s records began in 1967. The number of unemployed people in...
Published:
Last Updated:
It seems impossible that a handful of companies could put nearly 80,000 people out of work in a day. Caterpillar (CAT), Pfizer (PFE), Texas Instruments (TXN), Sprint (S), and Home Depot (HD) did most...
Published:
Last Updated: